Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy

[1]  É. Audet-Walsh,et al.  Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  B. Viollet,et al.  AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation , 2018, Nature Communications.

[3]  R. Shaw,et al.  AMPK: guardian of metabolism and mitochondrial homeostasis , 2017, Nature Reviews Molecular Cell Biology.

[4]  M. Estrada,et al.  Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy , 2017, Front. Pharmacol..

[5]  M. Erion,et al.  Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy , 2017, Science.

[6]  G. Stephanopoulos,et al.  Akt regulation of glycolysis mediates bioenergetic stability in epithelial cells , 2017, bioRxiv.

[7]  R. Tian,et al.  Metabolism in cardiomyopathy: every substrate matters , 2017, Cardiovascular research.

[8]  K. Channer,et al.  Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse , 2016, Endocrine.

[9]  R. Kloner,et al.  Testosterone and Cardiovascular Disease. , 2016, Journal of the American College of Cardiology.

[10]  R. Davey,et al.  Androgen Receptor Structure, Function and Biology: From Bench to Bedside. , 2016, The Clinical biochemist. Reviews.

[11]  G. Pourmand,et al.  The Association between Androgenic Hormone Levels and the Risk of Developing Coronary Artery Disease (CAD) , 2016, Iranian journal of public health.

[12]  R. Tian,et al.  Glucose Transporters in Cardiac Metabolism and Hypertrophy. , 2015, Comprehensive Physiology.

[13]  B. Yeap.  Testosterone and cardiovascular disease risk , 2015, Current opinion in endocrinology, diabetes, and obesity.

[14]  G. Hackett,et al.  Testosterone Deficiency, Cardiac Health, and Older Men , 2014, International journal of endocrinology.

[15]  C. Allan.  Sex steroids and glucose metabolism , 2014, Asian journal of andrology.

[16]  S. Javadov,et al.  Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria , 2014, Journal of cellular and molecular medicine.

[17]  Robert A. Kloner,et al.  Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature , 2013, Journal of the American Heart Association.

[18]  M. Estrada,et al.  Testosterone increases GLUT4‐dependent glucose uptake in cardiomyocytes , 2013, Journal of cellular physiology.

[19]  Jayantha B. Tennakoon,et al.  Androgens Regulate Prostate Cancer Cell Growth via an AMPK-PGC-1α-Mediated Metabolic Switch , 2013, Oncogene.

[20]  M. Estrada,et al.  Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. , 2013, Medicine and science in sports and exercise.

[21]  R. Tian,et al.  Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. , 2013, Circulation research.

[22]  B. Cho,et al.  The Role of Androgen in the Adipose Tissue of Males , 2013, The world journal of men's health.

[23]  M. Ruel,et al.  Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes. , 2013, Journal of molecular and cellular cardiology.

[24]  H. Huikuri,et al.  Total testosterone levels, metabolic parameters, cardiac remodeling and exercise capacity in coronary artery disease patients with different stages of glucose tolerance , 2013, Annals of medicine.

[25]  G. Lopaschuk,et al.  Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. , 2013, Biochimica et biophysica acta.

[26]  Xinli Hu,et al.  Microtubule Actin Cross-Linking Factor 1 Regulates Cardiomyocyte Microtubule Distribution and Adaptation to Hemodynamic Overload , 2013, American journal of physiology. Heart and circulatory physiology.

[27]  Shuichi Sato,et al.  Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle , 2013, Molecular and Cellular Endocrinology.

[28]  S. Yoshida,et al.  Effects of androgens on cardiovascular remodeling. , 2012, The Journal of endocrinology.

[29]  C. Caldarera,et al.  Evidence that AMP-activated protein kinase can negatively modulate ornithine decarboxylase activity in cardiac myoblasts. , 2012, Biochimica et biophysica acta.

[30]  A. Isidori,et al.  Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review , 2012, Current diabetes reviews.

[31]  P. Dandona,et al.  Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. , 2011, The Journal of clinical endocrinology and metabolism.

[32]  R. Tian,et al.  Glucose metabolism and cardiac hypertrophy. , 2011, Cardiovascular research.

[33]  E. Abel,et al.  Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. , 2011, Cardiovascular research.

[34]  J. Vicencio,et al.  Anabolic androgenic steroids and intracellular calcium signaling: a mini review on mechanisms and physiological implications. , 2011, Mini reviews in medicinal chemistry.

[35]  Matthew T. Haren,et al.  Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. , 2011, International journal of andrology.

[36]  S. Romashkan,et al.  Why Do We Need a Trial on the Effects of Testosterone Therapy in Older Men? , 2011, Clinical pharmacology and therapeutics.

[37]  S. Fernando,et al.  Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass. , 2010, Endocrinology.

[38]  V. Rajapurohitam,et al.  Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes. , 2010, American journal of physiology. Heart and circulatory physiology.

[39]  M. Bunck,et al.  Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. , 2009, Journal of andrology.

[40]  K. Balasubramanian,et al.  Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat. , 2009, Metabolism: clinical and experimental.

[41]  M. Estrada,et al.  Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway. , 2009, The Journal of endocrinology.

[42]  E. Isenovic,et al.  AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C. , 2009, Biochemical pharmacology.

[43]  P. Bouloux,et al.  Testosterone therapy in men , 2009, Menopause international.

[44]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[45]  L. Gooren,et al.  The role of testosterone in the metabolic syndrome: A review , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  U. Laufs,et al.  Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[47]  R. Ajisaka,et al.  Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. , 2008, American journal of physiology. Endocrinology and metabolism.

[48]  B. Kemp,et al.  AMP-Activated Protein Kinase Regulates GLUT4 Transcription by Phosphorylating Histone Deacetylase 5 , 2008, Diabetes.

[49]  Mohit M. Jain,et al.  Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress , 2007, Circulation.

[50]  K. Balasubramanian,et al.  Testosterone deficiency impairs glucose oxidation through defective insulin and its receptor gene expression in target tissues of adult male rats. , 2007, Life sciences.

[51]  J. Seidman,et al.  AMP-Activated Protein Kinase in the Heart: Role During Health and Disease , 2007, Circulation research.

[52]  B. Lunenfeld.  Testosterone deficiency and the metabolic syndrome , 2007, The aging male : the official journal of the International Society for the Study of the Aging Male.

[53]  D. Hood,et al.  AMP-Activated Protein Kinase-Regulated Activation of the PGC-1α Promoter in Skeletal Muscle Cells , 2006, PloS one.

[54]  B. Lorell,et al.  Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart , 2004, Hypertension.

[55]  Anita Y. M. Chan,et al.  Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.

[56]  W. Kindermann,et al.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? , 2004, Heart.

[57]  M. Estrada,et al.  Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes* , 2004, Journal of Biological Chemistry.

[58]  R. Tian.  Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart , 2003, Current hypertension reports.

[59]  B. Kemp.  Faculty Opinions recommendation of Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. , 2003 .

[60]  Jérôme Boudeau,et al.  Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.

[61]  C. Sultan,et al.  Molecular action of androgens , 2002, Molecular and Cellular Endocrinology.

[62]  R. Franklin,et al.  Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[63]  P. Hruz,et al.  Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations , 2002, AIDS.

[64]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[65]  J. Psotová,et al.  Neonatal rat cardiomyocytes--a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. , 2001, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[66]  D. Carling,et al.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.

[67]  D. Neal,et al.  Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  R. Steeds,et al.  Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. , 2000, European heart journal.

[69]  A. Thorburn,et al.  Transcriptional Activation of the Glucose Transporter GLUT1 in Ventricular Cardiac Myocytes by Hypertrophic Agonists* , 1999, The Journal of Biological Chemistry.

[70]  J. Gwathmey,et al.  Androgen receptors mediate hypertrophy in cardiac myocytes. , 1998, Circulation.

[71]  G. Lopaschuk,et al.  Contribution of glycogen and exogenous glucose to glucose metabolism during ischemia in the hypertrophied rat heart. , 1997, Circulation research.

[72]  M. Palacín,et al.  Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. , 1997, The American journal of cardiology.

[73]  M. Palacín,et al.  Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes , 1997, The Journal of Biological Chemistry.

[74]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[75]  M. Rovetto,et al.  Mechanisms of Glycolytic Inhibition in Ischemic Rat Hearts , 1975, Circulation research.

[76]  J. Williamson.  GLYCOLYTIC CONTROL MECHANISMS. I. INHIBITION OF GLYCOLYSIS BY ACETATE AND PYRUVATE IN THE ISOLATED, PERFUSED RAT HEART. , 1965, The Journal of biological chemistry.

[77]  M. Teitell,et al.  Techniques to monitor glycolysis. , 2014, Methods in enzymology.

[78]  S. McGee,et al.  AMPK and transcriptional regulation. , 2008, Frontiers in bioscience : a journal and virtual library.

[79]  E. Barrett-Connor,et al.  Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.

[80]  R. Brownsey,et al.  AMPK and metabolic adaptation by the heart to pressure overload. , 2007, American journal of physiology. Heart and circulatory physiology.